SCHEMBL29327900

SCHEMBL29327900

CCc1ccc(-c2cc3cc(NC(=O)c4cc(C#N)ccc4S(=O)(=O)C(F)(F)F)ccc3cn2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 5/20 0.46
▸ TP53 P04637 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ NPC1 O15118 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SGK1 O00141 1/20 0.37
▸ TMPRSS4 Q9NRS4 1/20 0.37
▸ VCP P55072 1/20 0.36
▸ PPARA Q07869 1/20 0.35
▸ F2 P00734 1/20 0.35
▸ PLG P00747 1/20 0.35
▸ PLAU P00749 1/20 0.35
▸ KLKB1 P03952 1/20 0.35
▸ PRSS1 P07477 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SCN2A Q99250 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29327911 0.97 PPARG (0.46) PPARGTP53THRBNPC1MEN1
SCHEMBL29327871 0.92 PPARG (0.48) PPARGTP53THRBNPC1MEN1
SCHEMBL29327877 0.88 PPARG (0.48) PPARGTP53THRBNPC1MEN1
SCHEMBL29327987 0.83 PPARG (0.44) PPARGTP53THRBNPC1MEN1
SCHEMBL29327924 0.82 PPARG (0.49) PPARGTP53THRBNPC1MEN1
SCHEMBL29327967 0.82 NPC1 (0.40) PPARGTP53THRBNPC1MEN1
SCHEMBL29327928 0.81 APP (0.48) PPARGTP53THRBNPC1ALDH1A1
SCHEMBL29327992 0.80 PPARG (0.44) PPARGTP53THRBNPC1MEN1
SCHEMBL29327715 0.80 PPARG (0.47) PPARGTP53THRBNPC1KMT2A
SCHEMBL29327713 0.80 PPARG (0.63) PPARGTP53THRBNPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239760-A1 PPARG INVERSE AGONISTS AND USES THEREOF FLARE THERAPEUTICS INC. 2024-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239760-A1 PPARG INVERSE AGONISTS AND USES THEREOF PPARG, PPARA, PPARD PPARG 1/4885TP53 1398/4885THRB 89/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback